Forskning ved Københavns Universitet - Københavns Universitet

Forside

Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays. / Engle, Ronald E; Russell, Rodney S; Purcell, Robert H; Bukh, Jens.

I: Journal of Medical Virology, Bind 80, Nr. 1, 2008, s. 72-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Engle, RE, Russell, RS, Purcell, RH & Bukh, J 2008, 'Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays', Journal of Medical Virology, bind 80, nr. 1, s. 72-9. https://doi.org/10.1002/jmv.21043

APA

Engle, R. E., Russell, R. S., Purcell, R. H., & Bukh, J. (2008). Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays. Journal of Medical Virology, 80(1), 72-9. https://doi.org/10.1002/jmv.21043

Vancouver

Engle RE, Russell RS, Purcell RH, Bukh J. Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays. Journal of Medical Virology. 2008;80(1):72-9. https://doi.org/10.1002/jmv.21043

Author

Engle, Ronald E ; Russell, Rodney S ; Purcell, Robert H ; Bukh, Jens. / Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays. I: Journal of Medical Virology. 2008 ; Bind 80, Nr. 1. s. 72-9.

Bibtex

@article{848046c0f8f811ddb219000ea68e967b,
title = "Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays",
abstract = "A quantitative real-time PCR assay was developed that detects genomic RNA from reference strains representing the six major genotypes of hepatitis C virus (HCV) with equal sensitivity and accurately measured HCV RNA in JFH1 HCV-infected Huh7.5 cells. The method is indirectly calibrated to the first international (WHO 96/790) HCV standard preparation and has a linear dynamic range of 10(2.6)-10(6.5) IU/ml. In addition, the inter- and intra-assay precision were approximately 3% CV and <2% CV, respectively. Comparison with results obtained by commercially available HCV RNA Nucleic Acid Technology kits (Versant HCV RNA 3.0 b-DNA and Amplicor HCV Monitor), that also employ the WHO standard, allowed validation of the TaqMan assay against all major HCV genotypes. Both commercial methods detected HCV RNA over a wide dynamic range, but showed a consistent difference of about 0.3 log10 when evaluating samples of different HCV genotypes. The genome titers obtained with the three methods correlated with the infectivity titers previously determined for the HCV reference strains. TaqMan assays have become an essential tool to follow viral load in clinical samples and cell culture-based experiments and this technology offers significant advantages in linear dynamic range, sensitivity and customization.",
author = "Engle, {Ronald E} and Russell, {Rodney S} and Purcell, {Robert H} and Jens Bukh",
note = "(c) 2007 Wiley-Liss, Inc.",
year = "2008",
doi = "10.1002/jmv.21043",
language = "English",
volume = "80",
pages = "72--9",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "JohnWiley & Sons, Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays

AU - Engle, Ronald E

AU - Russell, Rodney S

AU - Purcell, Robert H

AU - Bukh, Jens

N1 - (c) 2007 Wiley-Liss, Inc.

PY - 2008

Y1 - 2008

N2 - A quantitative real-time PCR assay was developed that detects genomic RNA from reference strains representing the six major genotypes of hepatitis C virus (HCV) with equal sensitivity and accurately measured HCV RNA in JFH1 HCV-infected Huh7.5 cells. The method is indirectly calibrated to the first international (WHO 96/790) HCV standard preparation and has a linear dynamic range of 10(2.6)-10(6.5) IU/ml. In addition, the inter- and intra-assay precision were approximately 3% CV and <2% CV, respectively. Comparison with results obtained by commercially available HCV RNA Nucleic Acid Technology kits (Versant HCV RNA 3.0 b-DNA and Amplicor HCV Monitor), that also employ the WHO standard, allowed validation of the TaqMan assay against all major HCV genotypes. Both commercial methods detected HCV RNA over a wide dynamic range, but showed a consistent difference of about 0.3 log10 when evaluating samples of different HCV genotypes. The genome titers obtained with the three methods correlated with the infectivity titers previously determined for the HCV reference strains. TaqMan assays have become an essential tool to follow viral load in clinical samples and cell culture-based experiments and this technology offers significant advantages in linear dynamic range, sensitivity and customization.

AB - A quantitative real-time PCR assay was developed that detects genomic RNA from reference strains representing the six major genotypes of hepatitis C virus (HCV) with equal sensitivity and accurately measured HCV RNA in JFH1 HCV-infected Huh7.5 cells. The method is indirectly calibrated to the first international (WHO 96/790) HCV standard preparation and has a linear dynamic range of 10(2.6)-10(6.5) IU/ml. In addition, the inter- and intra-assay precision were approximately 3% CV and <2% CV, respectively. Comparison with results obtained by commercially available HCV RNA Nucleic Acid Technology kits (Versant HCV RNA 3.0 b-DNA and Amplicor HCV Monitor), that also employ the WHO standard, allowed validation of the TaqMan assay against all major HCV genotypes. Both commercial methods detected HCV RNA over a wide dynamic range, but showed a consistent difference of about 0.3 log10 when evaluating samples of different HCV genotypes. The genome titers obtained with the three methods correlated with the infectivity titers previously determined for the HCV reference strains. TaqMan assays have become an essential tool to follow viral load in clinical samples and cell culture-based experiments and this technology offers significant advantages in linear dynamic range, sensitivity and customization.

U2 - 10.1002/jmv.21043

DO - 10.1002/jmv.21043

M3 - Journal article

C2 - 18041021

VL - 80

SP - 72

EP - 79

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 1

ER -

ID: 10484342